N-Acetylcysteine Applications in Biofilm Disruption

N-Acetylcysteine (NAC) is a small, thiol-containing molecule originally employed as a mucolytic and antioxidant. More recently, it has emerged as a versatile anti-biofilm agent through multiple mechanisms. Its free thiol group reduces disulfide bonds within extracellular polymeric substances, destabilising the biofilm matrix and enhancing penetration of antimicrobial agents. As a weak acid, NAC can lower local pH and disrupt microbial cells embedded in biofilms. Strategies range from systemic or topical administration to covalent immobilisation on medical-device coatings, ensuring sustained high local concentrations. Practical applications span treatment of chronic respiratory infections, prevention of catheter and implant-associated infections, management of urinary tract infections and novel water-system treatments. By weakening biofilm structure and sensitising bacteria to antibiotics, NAC offers a promising adjunct in the global effort to combat antibiotic resistance and persistent infections.

Research from Nature Portfolio

Innovative surface-coating approaches have been developed in which NAC is covalently bound to chitosan-derived films using water-based carbodiimide chemistry. Surface characterisation confirmed stable immobilisation, and quantitative assays demonstrated that these NAC-functionalised coatings markedly reduce protein adsorption and prevent adhesion of methicillin-resistant Staphylococcus aureus without cytotoxicity. This work illustrates the utility of immobilised NAC for long-lasting implant protection.

Mechanistic studies of NAC as a weak organic acid against mucoid Pseudomonas aeruginosa biofilms have revealed that when applied at pH below its pKa, NAC penetrates the matrix, achieves full eradication of embedded bacteria and induces passive shedding of microcolonies. Following bacterial death, the remnant matrix behaves as a pH-responsive hydrogel, shedding new light on biofilm architecture and informing future design of responsive soft materials and targeted eradication strategies.

N-Acetylcysteine Applications in Biofilm Disruption publication trend

The graph below shows the total number of articles in n-acetylcysteine applications in biofilm disruption across all publications each year (not limited to Nature Index journals).

Technical terms

Biofilm: A structured community of microbial cells enclosed in a self-produced polymeric matrix and adherent to an inert or living surface.

Extracellular polymeric substance (EPS): The complex mixture of polysaccharides, proteins, lipids and extracellular DNA that forms the biofilm matrix.

Minimum inhibitory concentration (MIC): The lowest concentration of an antimicrobial agent that prevents visible growth of a microorganism in vitro.

Minimum biofilm inhibitory concentration (MBIC): The lowest concentration of an agent that prevents biofilm formation without necessarily killing planktonic cells.

Covalent immobilisation: The chemical attachment of a bioactive molecule to a surface via stable covalent bonds, ensuring prolonged local activity.

pKa: The acid dissociation constant; the pH at which half of the acidic groups of a compound are deprotonated, influencing its charge and penetration into biofilms.

References

1. Effect of N-Acetyl-L-cysteine on Activity of Doxycycline against Biofilm-Forming Bacterial Strains. Antibiotics (2023).
2. N-acetylcysteine-functionalized coating avoids bacterial adhesion and biofilm formation. Scientific Reports (2017).
3. Mechanistic action of weak acid drugs on biofilms. Scientific Reports (2017).
4. Antimicrobial and Antibiofilm N-acetyl-L-cysteine Grafted Siloxane Polymers with Potential for Use in Water Systems. International Journal of Molecular Sciences (2019).
5. N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review. Pharmaceuticals (2022).
6. N-Acetylcysteine Protects Bladder Epithelial Cells from Bacterial Invasion and Displays Antibiofilm Activity against Urinary Tract Bacterial Pathogens. Antibiotics (2021).